Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company") a company pioneering innovation at the inters...
Entero Therapeutics (NASDAQ:ENTO) didn't tiptoe into reinvention. It jumped. The company, once known for enzymes and patien...
U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures of major benchmark indices w...
US stock futures mixed, with attention on earnings reports from companies like AngioDynamics, Grindr, and Entero Therapeutics.
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler...
-SEC Filing
